(Microsoft PowerPoint - Presentation template M\374nster

advertisement
NanoBioAnalytics-Region
Münster
Concept and Background
HORIZON 2020
EUROPEAN UNION FUNDING
FOR RESEARCH & INNOVATION
Our interest
Analysis of cell - material interactions
Fromherz, Munich
Strong analytical location
Electron Microscopy (1970)
(20)
Mass Spectrometry (1980)
Ions (SIMS) (15)
Laser (MALDI) (6)
Atomic Force Microscopy (1990)
(40)
Ion Sputtering (2000)
(2)
Competitive biomedical research
Max-Planck Institute fo Molecular Biomedicine
Research Topics
• Prof. Schöler
•Stem cell differentiation
•Prof. Adam
•Blood vessel development
•Prof. Vestweber
•Immune response in blood cells
Large University Clinic
Clinic area
• 70 clinics and institutes
• 160 Professors
• 7000 Employees
• 400,000 Patients per year
• Strong focus on research
Research area
• Five main research areas
• Inflammation and transplantation
• Cardiovascular medicine
• Tumor medicine
• Neuro medicine
• Reproduction and Regeneration medicine
Companies
30 Companies with more than 1000 employees
Nano Analytics
Bio
Medicine
Goal
Develop Münster
into a leading
Nano-BioAnalytics
location in Europa
Infrastructure
Science Park Münster
NBZ
MPI
Clinics
IONTOF
T-Hof
CeNTech
Geo
Pharmaceutics
Chemistry
Physics
MEET
Municipal ivestments in infrastructure
•
Year
Investment
City of Münster*
BioZ
2002
4,6 Mio. Euro
4,6 Mio. Euro
CeNTech I
2003
8,7 Mio. Euro
3 Mio. Euro
CeNTech II
2011
7,5 Mio. Euro
House builder function
NBZ
2011
16,2 Mio. Euro 3 Mio. Euro
oder städtische Gesellschaften wie Wirtschaftsförderung Münster GmbH, Technologieförderung Münster GmbH oder CeNTech GmbH
Strategic
Networking
Co-ordinated network
Science
Transfer
Economy
Technologiepark
Universities
Town of
Münster
Investors
Other
partners
Bio.NRW
young
Start-Ups
Founder of
companies
Research
centers
IHK
Münster
CeNTech
Kompetenzzentrum
Nanoanalytik
Established
companies
Status 2000
MPI
MPI
CeNTech
EIMI
City
UNI
Status 2014
UNI
FH
EIMI
MPI
UKM
Companies
CeNTech
City
Communication of Science in Münster
NanoBioAnalytik
in Medtech
and Pharma
Medical
Prevention
Westfalian Peace
1648 – Dialogue
for Peace
Strategic partnership in NRW
Bio
BIO.NRW
Strategic partnership in NRW
Nano
Cluster
Nano/Micro+
Materials.NRW
Strategic Partners at national level
in the field of Bio
Strategic Partners at European level
in the field of NanoBio
Uni Lund
MIC Copenhagen
Mesa+ Twente
Tyndall Cork
INSAT Newcastle
Bioanalytik, Uni Münster, Centech
Uni Mainz, Uni Saarland, Uni Kaiserslautern
NanoBioNet, IBMT
CEA, CNRS, INSERM
EPFL Lausanne, FSRM
PCB Barcelona
JRC Ispra
Demokritos Athens, FORTH
Uni Tel Aviv
Strategic partnership at European level
Strategic Projects in
Nanosafety
Technologies
Mass Spectrometry
Electron Microscopy
Holographie
AFM
XPS und LEIS
Optical Profilometry
AFM
Holography
Flow and Scanning Cytometry
TOF SIMS
REM/SEM
Test systems
Lung and particle research
with industrial partners
Analysis of dynamic
processes in human cell
systems by optical
methods
Development and validation
of in vitro systems as
replacement for animal
testing.
Alveolarmakrophage
P. Boisseau Twente July 6, 2005
2
3
Applications
Food and Feed
Pharmaceuticals
Cosmetics
Environment
Occupational safety
Cells and tissues
Consumer products
Alveolarmakrophage
QM-based nano-characterization
Industrial
Customers
Environment
Food
Cosmetics
Pharma
www.ncl-muenster.de
EU-NCL concept of operation
Metrology Institutes
Sources
of materials
Regulatory bodies
EU-NCL
Analytical report
for pre-clinical tests
Academia
RTO
Prevention
Characterization cascade
SMEs
Pharma
Diagnostics
Therapeutics
Physical and
chemical characterization
Regenerative medicine
In vitro assays
In vivo assays
European landscape for EU-NCL
European
Partners
• CEA Grenoble and
Saclay (France)
• Bioanalytikmuenster
(Germany)
• JRC-IHCP (Italy)
• EMPA (Switzerland)
• SINTEF (Norway)
• CRANN (Ireland)
• Uni Liverpool (UK)
US Partner
• NCI-NCL
JRC-IHCP
EU-NCL Münster
30
Download